Neurocognition in bipolar disorders--a closer look at comorbidities and medications.

@article{BalanzMartinez2010NeurocognitionIB,
  title={Neurocognition in bipolar disorders--a closer look at comorbidities and medications.},
  author={V Balanz{\'a}-Martinez and Gabriel Selva and Anabel Mart{\'i}nez-Ar{\'a}n and Jos Prickaerts and Jos{\'e} Manuel Salazar and Ana Gonzalez-Pinto and Eduard Vieta and Rafael Tabar{\'e}s-Seisdedos},
  journal={European journal of pharmacology},
  year={2010},
  volume={626 1},
  pages={87-96}
}
The last decade has witnessed a growing interest in the neuropsychological study of bipolar disorder (BD). This chronic mood disorder is associated with persistent neurocognitive impairments even during periods of euthymia, particularly in the broad domains of attention, verbal memory and executive functions. More interestingly, cognitive dysfunction seems to predict a poorer functional outcome among BD patients and thus represents an important target for future therapies. The aetiology of… CONTINUE READING